Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.133.91.171
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Hematology
Trending Topics

Case Report: Simultaneous Evans Syndrome and Primary Antiphospholipid Syndrome

Posted on

In this case report, a 67-year-old man with type 2 diabetes mellitus, hypertension, and renal insufficiency presented with concomitant Evans syndrome (ES), a rare autoimmune disorder in which the person’s own antibodies destroys the body’s red blood cells, white blood cells, and/or platelets, and primary antiphospholipid syndrome (APS).

In 2013, the patient was diagnosed with APS after suffering a deep vein thrombosis of the left lower extremity and started on chronic warfarin. In 2014, he was diagnosed with immune thrombocytopenia (ITP), with a relapse the following year. In addition, the patient was diagnosed with autoimmune hemolytic anemia (AIHA)

-Advertisement-
-Advertisement-

The diagnosis of ES was based off his previous episodes of ITP and current AIHA. He was treated with 100 mg prednisone taper. Rituximab was added for complete platelet recovery.

The authors concluded that, “the severe deterioration and rapid recovery with proper treatment of the patient highlights the importance of a timely diagnosis of ES.”

Read the full case report here.

Reference

Patel BP and Jakob J. A rare case of simultaneous evans syndrome and primary antiphospholipid syndrome. Cureus. 2020;12(2):e6845.

-Advertisement-
Related Articles
Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment
Jun 01, 2021
ASH: Novel Fetal Hemoglobin Repressor for Sickle Cell Disease Identified
May 31, 2020
Education and Support Enhance Care for Rare-Disease Patients
Mar 27, 2020
-Advertisement-
-Advertisement-
-Advertisement-